{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:26:22Z","timestamp":1779179182987,"version":"3.51.4"},"reference-count":21,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1401221, 81500149, 81470349"],"award-info":[{"award-number":["U1401221, 81500149, 81470349"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2014B020226004"],"award-info":[{"award-number":["2014B020226004"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00962","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T03:45:42Z","timestamp":1502682342000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Mesenchymal Stem Cells May Ameliorate Nephrotic Syndrome Post-Allogeneic Hematopoietic Stem Cell Transplantation-Case Report"],"prefix":"10.3389","volume":"8","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guobao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AndyPeng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qifa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.coi.2006.07.004","article-title":"Mesenchymal stem cells: properties and role in clinical bone marrow transplantation","volume":"18","author":"Le Blanc","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/ndt\/gfl795","article-title":"Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects","volume":"22","author":"Terrier","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bcmd.2010.12.003","article-title":"Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation: etiology and pathogenesis","volume":"46","author":"Luo","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/1871525711311010011","article-title":"The management of membranous glomerulopathy in allogeneic stem cells transplantation: updated literature","volume":"11","author":"Niscola","year":"2013","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"B5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1756-8722-6-15","article-title":"Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study","volume":"6","author":"Liu","year":"2013","journal-title":"J Hematol Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-016-0276-z","article-title":"The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation","volume":"9","author":"Zhao","year":"2016","journal-title":"J Hematol Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/leu.2014.225","article-title":"Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10","volume":"29","author":"Peng","year":"2015","journal-title":"Leukemia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/bmt.2010.195","article-title":"Mesenchymal stem cell as salvage treatment for refractory chronic GVHD","volume":"45","author":"Weng","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jcyt.2013.08.002","article-title":"Protective effects of mesenchymal stromal cells on adriamycin-induced minimal change nephrotic syndrome in rats and possible mechanisms","volume":"16","author":"Guo","year":"2014","journal-title":"Cytotherapy"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial","volume":"307","author":"Tan","year":"2012","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/cei.12675","article-title":"Regulatory T cells and minimal change nephropathy: in the midst of a complex network","volume":"183","author":"Bertelli","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1182\/blood-2015-09-668145","article-title":"Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice","volume":"127","author":"Jin","year":"2015","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2011-07-364414","article-title":"Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans","volume":"119","author":"Srinivasan","year":"2012","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1182\/blood-2013-10-533562","article-title":"Increased BCR responsiveness in B cells from patients with chronic GVHD","volume":"123","author":"Allen","year":"2014","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2014-12-567834","article-title":"Aberrant B-cell homeostasis in chronic GVHD","volume":"125","author":"Sarantopoulos","year":"2015","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1182\/blood-2014-09-599159","article-title":"CD24(hi)CD27(+) and plasmablast-like regulatory B cells in human chronic graft-versus-host disease","volume":"125","author":"de Masson","year":"2015","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.5966\/sctm.2014-0001","article-title":"Alteration of na\u00efve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells","volume":"3","author":"Peng","year":"2014","journal-title":"Stem Cells Transl Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1056\/NEJMc0808481","article-title":"B-cell-depleting induction therapy and acute cellular rejection","volume":"360","author":"Clatworthy","year":"2009","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1089\/scd.2009.0345","article-title":"Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders","volume":"19","author":"Zhao","year":"2010","journal-title":"Stem Cells Dev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.molimm.2014.01.014","article-title":"Cellular targets of regulatory B cell-mediated suppression","volume":"62","author":"Rosser","year":"2014","journal-title":"Mol Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1016\/j.febslet.2015.08.048","article-title":"The regulatory role of B cells in autoimmunity, infections and cancer: perspectives beyond IL10 production","volume":"589","author":"Gorosito","year":"2015","journal-title":"FEBS Lett"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00962\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T03:45:45Z","timestamp":1502682345000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00962\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,14]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2017.00962"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00962","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,14]]},"article-number":"962"}}